HEADER LIPID BINDING PROTEIN 22-JAN-18 6FJD TITLE HUMAN KIBRA C2 DOMAIN MUTANT C771A IN COMPLEX WITH TITLE 2 PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KIBRA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HBEAG-BINDING PROTEIN 3,KIDNEY AND BRAIN PROTEIN,KIBRA,WW COMPND 5 DOMAIN-CONTAINING PROTEIN 1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: WWC1, KIAA0869; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS C2 DOMAIN, KIBRA, PHOSPHOINOSITIDE-BINDING, MEMBRANE INTERACTION, KEYWDS 2 LIPID BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.J.CRENNELL,M.G.POSNER,S.BAGBY REVDAT 3 17-JAN-24 6FJD 1 COMPND HETNAM REVDAT 2 27-JUN-18 6FJD 1 JRNL ATOM REVDAT 1 16-MAY-18 6FJD 0 JRNL AUTH M.G.POSNER,A.UPADHYAY,R.ISHIMA,A.C.KALLI,G.HARRIS, JRNL AUTH 2 J.KREMERSKOTHEN,M.S.P.SANSOM,S.J.CRENNELL,S.BAGBY JRNL TITL DISTINCTIVE PHOSPHOINOSITIDE- AND CA2+-BINDING PROPERTIES OF JRNL TITL 2 NORMAL AND COGNITIVE PERFORMANCE-LINKED VARIANT FORMS OF JRNL TITL 3 KIBRA C2 DOMAIN. JRNL REF J. BIOL. CHEM. V. 293 9335 2018 JRNL REFN ESSN 1083-351X JRNL PMID 29724824 JRNL DOI 10.1074/JBC.RA118.002279 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.12RC0_2797: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.47 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 10100 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 506 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.4712 - 4.5967 1.00 2531 151 0.2126 0.2334 REMARK 3 2 4.5967 - 3.6507 0.99 2390 128 0.1696 0.2277 REMARK 3 3 3.6507 - 3.1898 1.00 2355 113 0.1995 0.2465 REMARK 3 4 3.1898 - 2.8985 0.99 2318 114 0.2609 0.2900 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.340 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 2152 REMARK 3 ANGLE : 1.012 2912 REMARK 3 CHIRALITY : 0.052 339 REMARK 3 PLANARITY : 0.004 357 REMARK 3 DIHEDRAL : 18.328 1298 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6FJD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-JAN-18. REMARK 100 THE DEPOSITION ID IS D_1200008450. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-OCT-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10159 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.898 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : 0.13400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.60600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.099 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BALBES REMARK 200 STARTING MODEL: 2Z0U REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS PH 8.0, 1.5M (NH4)2SO4, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.41800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 138.83600 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 104.12700 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 173.54500 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 34.70900 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 69.41800 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 138.83600 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 173.54500 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 104.12700 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 34.70900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 911 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 646 REMARK 465 ARG A 647 REMARK 465 GLY A 648 REMARK 465 SER A 649 REMARK 465 HIS A 650 REMARK 465 HIS A 651 REMARK 465 HIS A 652 REMARK 465 HIS A 653 REMARK 465 HIS A 654 REMARK 465 HIS A 655 REMARK 465 GLY A 656 REMARK 465 MET B 646 REMARK 465 ARG B 647 REMARK 465 GLY B 648 REMARK 465 SER B 649 REMARK 465 HIS B 650 REMARK 465 HIS B 651 REMARK 465 HIS B 652 REMARK 465 HIS B 653 REMARK 465 HIS B 654 REMARK 465 HIS B 655 REMARK 465 GLY B 656 REMARK 465 ARG B 753 REMARK 465 SER B 754 REMARK 465 HIS B 755 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH21 ARG A 714 O HOH A 903 1.53 REMARK 500 HZ2 LYS A 667 O HOH A 901 1.56 REMARK 500 HH12 ARG B 714 OE2 GLU B 757 1.60 REMARK 500 OG SER A 686 OD1 ASP A 722 1.97 REMARK 500 NZ LYS A 667 O HOH A 901 1.98 REMARK 500 O HOH A 903 O HOH A 909 1.99 REMARK 500 NH1 ARG A 753 O HOH A 902 2.00 REMARK 500 NH1 ARG B 714 OE2 GLU B 757 2.04 REMARK 500 NH2 ARG A 714 O HOH A 903 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 HH12 ARG B 776 OP3 PBU A 809 6555 1.50 REMARK 500 O HOH A 904 O HOH A 904 8555 1.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 680 -61.59 -92.80 REMARK 500 ASN A 727 68.33 33.74 REMARK 500 MET A 734 131.36 -177.63 REMARK 500 ARG A 753 -9.29 -55.36 REMARK 500 ILE B 680 -62.81 -95.24 REMARK 500 LEU B 689 87.82 -166.81 REMARK 500 MET B 734 149.59 -170.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 804 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 805 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 806 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 807 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 808 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PBU A 809 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 804 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6FB4 RELATED DB: PDB REMARK 900 6FB4 CONTAINS THE SAME PROTEIN WITHOUT LIGAND REMARK 900 RELATED ID: 6FD0 RELATED DB: PDB REMARK 900 A VARIANT OF THE SAME PROTEIN WITH NO LIGAND REMARK 900 RELATED ID: 6FJC RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITH PTDINS(3,4,5)P3 BOUND DBREF 6FJD A 658 785 UNP Q8IX03 KIBRA_HUMAN 658 785 DBREF 6FJD B 658 785 UNP Q8IX03 KIBRA_HUMAN 658 785 SEQADV 6FJD MET A 646 UNP Q8IX03 INITIATING METHIONINE SEQADV 6FJD ARG A 647 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD GLY A 648 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD SER A 649 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD HIS A 650 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD HIS A 651 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD HIS A 652 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD HIS A 653 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD HIS A 654 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD HIS A 655 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD GLY A 656 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD SER A 657 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD ALA A 771 UNP Q8IX03 CYS 771 ENGINEERED MUTATION SEQADV 6FJD MET B 646 UNP Q8IX03 INITIATING METHIONINE SEQADV 6FJD ARG B 647 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD GLY B 648 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD SER B 649 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD HIS B 650 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD HIS B 651 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD HIS B 652 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD HIS B 653 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD HIS B 654 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD HIS B 655 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD GLY B 656 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD SER B 657 UNP Q8IX03 EXPRESSION TAG SEQADV 6FJD ALA B 771 UNP Q8IX03 CYS 771 ENGINEERED MUTATION SEQRES 1 A 140 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER GLY SEQRES 2 A 140 ALA THR ARG ILE GLN ILE ALA LEU LYS TYR ASP GLU LYS SEQRES 3 A 140 ASN LYS GLN PHE ALA ILE LEU ILE ILE GLN LEU SER ASN SEQRES 4 A 140 LEU SER ALA LEU LEU GLN GLN GLN ASP GLN LYS VAL ASN SEQRES 5 A 140 ILE ARG VAL ALA VAL LEU PRO CYS SER GLU SER THR THR SEQRES 6 A 140 CYS LEU PHE ARG THR ARG PRO LEU ASP ALA SER ASP THR SEQRES 7 A 140 LEU VAL PHE ASN GLU VAL PHE TRP VAL SER MET SER TYR SEQRES 8 A 140 PRO ALA LEU HIS GLN LYS THR LEU ARG VAL ASP VAL CYS SEQRES 9 A 140 THR THR ASP ARG SER HIS LEU GLU GLU CYS LEU GLY GLY SEQRES 10 A 140 ALA GLN ILE SER LEU ALA GLU VAL ALA ARG SER GLY GLU SEQRES 11 A 140 ARG SER THR ARG TRP TYR ASN LEU LEU SER SEQRES 1 B 140 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER GLY SEQRES 2 B 140 ALA THR ARG ILE GLN ILE ALA LEU LYS TYR ASP GLU LYS SEQRES 3 B 140 ASN LYS GLN PHE ALA ILE LEU ILE ILE GLN LEU SER ASN SEQRES 4 B 140 LEU SER ALA LEU LEU GLN GLN GLN ASP GLN LYS VAL ASN SEQRES 5 B 140 ILE ARG VAL ALA VAL LEU PRO CYS SER GLU SER THR THR SEQRES 6 B 140 CYS LEU PHE ARG THR ARG PRO LEU ASP ALA SER ASP THR SEQRES 7 B 140 LEU VAL PHE ASN GLU VAL PHE TRP VAL SER MET SER TYR SEQRES 8 B 140 PRO ALA LEU HIS GLN LYS THR LEU ARG VAL ASP VAL CYS SEQRES 9 B 140 THR THR ASP ARG SER HIS LEU GLU GLU CYS LEU GLY GLY SEQRES 10 B 140 ALA GLN ILE SER LEU ALA GLU VAL ALA ARG SER GLY GLU SEQRES 11 B 140 ARG SER THR ARG TRP TYR ASN LEU LEU SER HET GOL A 801 14 HET GOL A 802 14 HET GOL A 803 14 HET GOL A 804 14 HET GOL A 805 14 HET GOL A 806 14 HET SO4 A 807 5 HET SO4 A 808 5 HET PBU A 809 67 HET GOL B 801 14 HET GOL B 802 14 HET SO4 B 803 5 HET SO4 B 804 5 HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETNAM PBU (2R)-3-{[(R)-HYDROXY{[(1R,2R,3S,4R,5R,6S)-2,3,6- HETNAM 2 PBU TRIHYDROXY-4,5-BIS(PHOSPHONOOXY) HETNAM 3 PBU CYCLOHEXYL]OXY}PHOSPHORYL]OXY}PROPANE-1 ,2-DIYL HETNAM 4 PBU DIBUTANOATE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN PBU DI-BUTANOYL L-ALPHA-PHOSPHATIDYL-D-MYO-INOSITOL 4,5- HETSYN 2 PBU BISPHOSPHATE; DI-C4-PIP2 FORMUL 3 GOL 8(C3 H8 O3) FORMUL 9 SO4 4(O4 S 2-) FORMUL 11 PBU C17 H33 O19 P3 FORMUL 16 HOH *53(H2 O) HELIX 1 AA1 ASN A 684 LEU A 689 1 6 HELIX 2 AA2 SER A 735 HIS A 740 1 6 HELIX 3 AA3 ASN B 684 LEU B 688 5 5 HELIX 4 AA4 SER B 735 HIS B 740 1 6 SHEET 1 AA1 4 LEU A 724 SER A 733 0 SHEET 2 AA1 4 GLN A 674 SER A 683 -1 N ILE A 679 O GLU A 728 SHEET 3 AA1 4 ARG A 661 ASP A 669 -1 N LYS A 667 O ALA A 676 SHEET 4 AA1 4 SER A 777 ASN A 782 -1 O TYR A 781 N ILE A 662 SHEET 1 AA2 3 LEU A 712 ARG A 714 0 SHEET 2 AA2 3 LYS A 695 LEU A 703 -1 N VAL A 700 O PHE A 713 SHEET 3 AA2 3 LEU A 718 ASP A 719 -1 O LEU A 718 N VAL A 696 SHEET 1 AA3 4 LEU A 712 ARG A 714 0 SHEET 2 AA3 4 LYS A 695 LEU A 703 -1 N VAL A 700 O PHE A 713 SHEET 3 AA3 4 THR A 743 THR A 751 -1 O THR A 743 N LEU A 703 SHEET 4 AA3 4 GLU A 758 SER A 766 -1 O ILE A 765 N LEU A 744 SHEET 1 AA4 4 LEU B 724 SER B 733 0 SHEET 2 AA4 4 GLN B 674 SER B 683 -1 N LEU B 682 O LEU B 724 SHEET 3 AA4 4 ARG B 661 ASP B 669 -1 N ASP B 669 O GLN B 674 SHEET 4 AA4 4 SER B 777 ASN B 782 -1 O TYR B 781 N ILE B 662 SHEET 1 AA5 3 LEU B 712 ARG B 714 0 SHEET 2 AA5 3 LYS B 695 LEU B 703 -1 N VAL B 700 O PHE B 713 SHEET 3 AA5 3 LEU B 718 ASP B 719 -1 O LEU B 718 N VAL B 696 SHEET 1 AA6 4 LEU B 712 ARG B 714 0 SHEET 2 AA6 4 LYS B 695 LEU B 703 -1 N VAL B 700 O PHE B 713 SHEET 3 AA6 4 THR B 743 THR B 751 -1 O ARG B 745 N ALA B 701 SHEET 4 AA6 4 GLU B 758 SER B 766 -1 O ILE B 765 N LEU B 744 SSBOND 1 CYS A 705 CYS A 711 1555 1555 2.03 SSBOND 2 CYS A 749 CYS A 759 1555 1555 2.05 SSBOND 3 CYS B 705 CYS B 711 1555 1555 2.03 SSBOND 4 CYS B 749 CYS B 759 1555 1555 2.06 CISPEP 1 LEU A 703 PRO A 704 0 -3.85 CISPEP 2 LEU B 703 PRO B 704 0 -0.05 SITE 1 AC1 5 GLN A 691 GLN A 694 LEU A 784 SER A 785 SITE 2 AC1 5 GLN B 764 SITE 1 AC2 7 GLN A 764 ILE A 765 SER A 766 TYR A 781 SITE 2 AC2 7 GOL A 803 SER B 766 TYR B 781 SITE 1 AC3 8 ILE A 765 SER A 766 GLU A 769 VAL A 770 SITE 2 AC3 8 SER A 777 ARG A 779 TYR A 781 GOL A 802 SITE 1 AC4 3 ARG A 661 HIS B 740 GLN B 741 SITE 1 AC5 3 ARG A 661 SER A 683 HIS B 740 SITE 1 AC6 4 TYR A 736 ALA A 771 ARG A 772 SER A 773 SITE 1 AC7 3 LYS A 667 GLY A 774 ARG A 776 SITE 1 AC8 3 ILE A 680 ASN A 727 SO4 B 804 SITE 1 AC9 4 ASN A 727 ARG A 776 VAL B 729 ARG B 776 SITE 1 AD1 2 ARG B 661 SER B 683 SITE 1 AD2 6 CYS B 705 GLU B 707 THR B 709 THR B 710 SITE 2 AD2 6 CYS B 711 LEU B 712 SITE 1 AD3 5 GLU A 670 HIS A 740 GLN A 741 ARG A 772 SITE 2 AD3 5 ARG B 661 SITE 1 AD4 3 SO4 A 808 LYS B 667 ARG B 776 CRYST1 83.404 83.404 208.254 90.00 90.00 120.00 P 61 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011990 0.006922 0.000000 0.00000 SCALE2 0.000000 0.013845 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004802 0.00000